GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medizen Humancare Inc Co Ltd (XKRX:236340) » Definitions » EV-to-EBIT

Medizen Humancare Co (XKRX:236340) EV-to-EBIT : -7.84 (As of Jun. 25, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Medizen Humancare Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medizen Humancare Co's Enterprise Value is ₩13,925 Mil. Medizen Humancare Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,775 Mil. Therefore, Medizen Humancare Co's EV-to-EBIT for today is -7.84.

The historical rank and industry rank for Medizen Humancare Co's EV-to-EBIT or its related term are showing as below:

XKRX:236340' s EV-to-EBIT Range Over the Past 10 Years
Min: -44.75   Med: -8.08   Max: -2.71
Current: -7.85

During the past 7 years, the highest EV-to-EBIT of Medizen Humancare Co was -2.71. The lowest was -44.75. And the median was -8.08.

XKRX:236340's EV-to-EBIT is ranked worse than
100% of 101 companies
in the Medical Diagnostics & Research industry
Industry Median: 19.75 vs XKRX:236340: -7.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medizen Humancare Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩12,433 Mil. Medizen Humancare Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,775 Mil. Medizen Humancare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -14.28%.


Medizen Humancare Co EV-to-EBIT Historical Data

The historical data trend for Medizen Humancare Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medizen Humancare Co EV-to-EBIT Chart

Medizen Humancare Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial -8.01 -4.86 -8.22 -7.14 -7.00

Medizen Humancare Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT Get a 7-Day Free Trial -8.01 -4.86 -8.22 -7.14 -7.00

Competitive Comparison of Medizen Humancare Co's EV-to-EBIT

For the Diagnostics & Research subindustry, Medizen Humancare Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medizen Humancare Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medizen Humancare Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medizen Humancare Co's EV-to-EBIT falls into.



Medizen Humancare Co EV-to-EBIT Calculation

Medizen Humancare Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=13925.136/-1775.282
=-7.84

Medizen Humancare Co's current Enterprise Value is ₩13,925 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medizen Humancare Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medizen Humancare Co  (XKRX:236340) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medizen Humancare Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-1775.282/12432.897
=-14.28 %

Medizen Humancare Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩12,433 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medizen Humancare Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-1,775 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medizen Humancare Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medizen Humancare Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medizen Humancare Co (XKRX:236340) Business Description

Traded in Other Exchanges
N/A
Address
Republic of Korea 223, Teheran-ro, Gangnam-gu, Seoul, KOR
Medizen Humancare Inc Co Ltd is a R&D company providing genomics involving acquisition of disease specific genome contents, identification of new drug candidate genes and development of new preventive measures.

Medizen Humancare Co (XKRX:236340) Headlines

No Headlines